Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
Outlining the latest government, industry, and public health efforts to promote increased adoption of common standards in data collection and sharing.
A look at the scope of the agency’s draft framework for evaluating the use of RWE to support new drug approvals and the implications for sponsors.
Starting with Eastern European sites in the 1990s, companies have increasingly selected investigator sites outside of North America and Western Europe.
Antimicrobial resistance remains a health and financial danger worldwide. Vaccines can both help reduce disease and combat antimicrobial resistance. Despite advancements, making antibacterial vaccines remains challenging.
Optimization model evaluates the benefits of selecting a portfolio of investigative sites based on advanced analytical models.
Portfolio simulation may be an effective tool to forecast achievability of COVID-19 portfolio strategic goals, including risk mitigation to boost vaccines development and production.
Over the past few months the majority of the news coming out of the pharmaceutical industry has been a refrain of slashing R&D spending as a result of increasingly competitive drug development.
A review of different statistical methods for data types and models used during research.
Survey uncovers deeper learnings of patient perceptions of clinical research and the motivations to participate.
Survey uncovers deeper learnings of patient perceptions of clinical research and the motivations to participate.
Apart from training and certifying individual EC members, the Dutch Central Committee on Research involving Human Subjects (CCMO) recently added training of investigators to its repertoire.
How the application of evolving M&S models are transforming full-research design strategies.
Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.
Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.
Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.
Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.
Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.